Oncology & Cancer

Recurrence score may cut costs for high-risk breast cancer care

(HealthDay)—Genomic recurrence score (RS) testing using a 21-gene assay is associated with decreased cancer care costs in real-world practice among certain patients with breast cancer who would otherwise receive standard ...

Medications

Dual receipt of opioids tied to increased risk for OD death

(HealthDay)—For veterans enrolled in the U.S. Department of Veterans Affairs (VA) and Medicare Part D, receipt of opioids from both VA and Part D is associated with an increased likelihood of death from prescription opioid ...

Cardiology

Odds of receiving tx for CAD up with medicare advantage

(HealthDay)—For patients with coronary artery disease (CAD), those enrolled in Medicare Advantage (MA) are more likely to receive secondary prevention treatments than those enrolled in traditional fee-for-service (FFS) ...

page 2 from 23